Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

Share Price is delayed by 15 minutes
Get Live Data
625.00    -27.00 (-4.14%)
Bid:
620.00
Ask:
630.00
Spread: 10.00 (1.613%)
Market Cap: £210.14m
AVG Live PriceLast checked at - London Stock Exchange

Intraday Avingtrans Share Chart

Employee & PDMR Share Incentive Awards

29 Nov 2021 17:57

RNS Number : 9423T
Avingtrans PLC
29 November 2021
 

 

Avingtrans plc

("Avingtrans", the "Company", or the "Group")

Employee & PDMR Share Incentive Awards

Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, announces that on 29 November 2021, the Board of Avingtrans, in accordance with the Company's Share Option Plan, granted options over 570,000 ordinary shares of 5p each in the Company ("Ordinary Shares") with an exercise price of 402.5 pence per Ordinary Share (the "Option Awards"). The following Option Awards were granted to Directors:

Director

Number of Ordinary Shares subject to Option Awards

Steve McQuillan

180,000

Stephen King

160,000

 

Furthermore Austen Adams, Managing Director of the Group's PSRE Division and a PDMR of the Company, has been granted Option Awards over a total of 110,000 Ordinary Shares.

The Option Awards may not be exercised until 3 years from the date of grant and are subject to a performance condition, being the increase in the Company's adjusted EPS must be at least equal to the increase in RPI over the vesting period.

 Enquiries:

Avingtrans plc

01354 692391

Roger McDowell, Chairman

Steve McQuillan, Chief Executive Officer Stephen King, Chief Financial Officer

Singer Capital Markets (Nominated Adviser)

02074 963000

Shaun Dobson

Alex Bond

Oliver Platts

Rachel Hayes

 

IFC Advisory Ltd

020 3934 6630

Graham Herring

Tim Metcalfe

Zach Cohen

 

About Avingtrans plc:

Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide.

Business units

Hayward Tyler - Luton & East Kilbride, UK and USA, China and India

Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments.

 

Energy Steel, Inc - Rochester Hills, Michigan, USA

Provider of custom fabrications for the nuclear industry, specialising in: OEM parts obsolescence; custom fabrications; engineering design solutions; product refurbishment; on-site technical support.

 

Stainless Metalcraft Ltd - Chatteris, UK and Chengdu, China

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems.

 

Booth Industries - Bolton, UK

Designs, manufactures, installs and services doors and walls which can be tailored to be: blast &explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above

 

Ormandy Group, Bradford, UK

Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products

 

Composite Products Ltd - Buckingham, UK

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

 

Magnetica Ltd - Brisbane, Australia

Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going. Magnetica's structure now includes two other business units:

 

Scientific Magnetics - Abingdon, UK

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments.

 

Tecmag Inc, Houston, USA

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

 

 

  

1

Details of the person discharging managerial responsibilities / person closely associated  

a)

 

Name 

Steve McQuillan

2

 

Reason for the notification

 

a)

 

Position/status

Chief Executive Officer

 

 

Initial notification /Amendment 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

a)

 

Name 

Avingtrans PLC

b)

 

LEI 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Options over Ordinary Shares of 5p each

 

 

Identification code

ISIN: GB0009188797

 

 

 

b)

 

Nature of the transaction 

Award of ordinary shares pursuant to the Company Share Option Plan

 

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Exercise Price(s)

Volume(s)

402.5 pence

180,000

 

 

 

d)

 

Aggregated information

n/a

 

 

- Aggregated volume

 

 

 

- Price

 

 

 

e)

 

Date of the transaction 

29 November 2021

f)

 

Place of the transaction

Off market

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Stephen King

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

 

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Avingtrans PLC

b)

 

LEI

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Options over Ordinary Shares of 5p each

 

 

Identification code

ISIN: GB0009188797

 

 

 

b)

 

Nature of the transaction

 

 

Award of ordinary shares pursuant to the Company Share Option Plan

 

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Exercise Price(s)

Volume(s)

402.5 pence

160,000

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

N/A

 

 

- Price

N/A

 

 

e)

 

Date of the transaction

 

29 November 2021

f)

 

Place of the transaction

 

Off-market

 

1

Details of the person discharging managerial responsibilities / person closely associated  

a)

 

Name 

Austen Adams

2

 

Reason for the notification

 

a)

 

Position/status

Managing Director, PSRE Division

 

 

Initial notification /Amendment 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

a)

 

Name 

Avingtrans PLC

b)

 

LEI 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Options over Ordinary Shares of 5p each

 

 

Identification code

ISIN: GB0009188797

 

 

 

b)

 

Nature of the transaction 

Award of ordinary shares pursuant to the Company Share Option Plan

 

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Exercise Price(s)

Volume(s)

402.5 pence

110,000

 

 

 

d)

 

Aggregated information

n/a

 

 

- Aggregated volume

 

 

 

- Price

 

 

 

e)

 

Date of the transaction 

29 November 2021

f)

 

Place of the transaction

Off market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKCBBOBDDFDB
Date   Source Headline
19th May 202610:20 amRNSHolding(s) in Company
14th May 202612:26 pmRNSHolding(s) in Company
12th May 20267:00 amRNSAdaptix receives CE Certification
6th May 20264:28 pmRNSHolding(s) in Company
30th Apr 20262:42 pmRNSHolding(s) in Company
30th Apr 20262:41 pmRNSExercise of Options & TVR
24th Apr 20262:54 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSStrong Nuclear Orders for Avingtrans
26th Mar 20267:00 amRNS-RScientific Magnetics Ships 20th Quantum Magnet
4th Mar 20267:00 amRNSHolding(s) in Company
25th Feb 20267:00 amRNSInterim Results
12th Feb 202611:49 amRNSHolding(s) in Company
6th Feb 202610:24 amRNSHolding(s) in Company
27th Jan 20265:42 pmRNSExercise of Options & TVR
21st Jan 20267:00 amRNSTrading Update and Notice of Results
12th Jan 20265:13 pmRNSIssue of Share Options
12th Jan 20267:00 amRNS-RMedical & Industrial Imaging Division Appointment
8th Dec 20252:34 pmRNSNotification of Major Holdings
27th Nov 20251:59 pmRNSResult of AGM - Board Appointment
14th Nov 20258:38 amRNSExercise of Options & PDMR Dealings
10th Nov 20257:00 amRNSAdaptix receives FDA 510(K) clearance
1st Oct 20254:52 pmRNSExercise of Options & Total Voting Rights
1st Oct 20253:32 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSAppointment of Medical Division CEO
24th Sep 20257:00 amRNSPreliminary results for the year ended 31 May 2025
11th Sep 20258:00 amRNSHolding(s) in Company
2nd Sep 20257:00 amRNSHayward Tyler Secures $16m Nuclear Contracts
28th Aug 20257:00 amRNSBooth Industries secures £8.5m HS2 & TfL contracts
25th Jun 20257:00 amRNSTrading Update and Notice of Results
28th May 20257:00 amRNSTrading Update
26th Feb 20257:00 amRNSInterim Results
13th Feb 20257:00 amRNSBooth Industries secures £4.5m Contract
16th Jan 20257:00 amRNSTrading Update & Notice of Results
21st Nov 20244:09 pmRNSResult of AGM
24th Oct 20249:07 amRNSHolding(s) in Company
25th Sep 20247:00 amRNSPreliminary results for the year ended 31 May 2024
3rd Jul 20247:00 amRNSPDMR Dealings
19th Jun 20247:00 amRNSTrading Update and Notice of Results
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.